Latest Period
n/a
Security Snapshot
Grace Therapeutics, Inc. - Common Stock (ACST) Institutional Ownership
CUSIP: 00430K865
13F Institutional Holders and Ownership History from Q3 2023 to Q4 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- ACST
- Shares outstanding
- 16,612,245
Security identity
Issuer context
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- ACST - Grace Therapeutics, Inc. - Common Stock is tracked under CUSIP 00430K865.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 0 between Q3 2024 and Q4 2024.
- Reported value moved from $3,483,534 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
00430K865
Latest holder period
n/a
13F holders
13D/G owners
2
CIK / CUSIP context first
ACST full holder history
Grace Therapeutics, Inc. SEC filings
Grace Therapeutics, Inc. company facts
Grace Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00430K865:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
ACST
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 9.9% | -0.9% | 1,534,254 | +2.1% | ADAR1 Capital Management GP, LLC | 30 Sep 2025 | ||
| HIRSCHMAN ORIN | 4.9% | 814,000 | Orin Hirschman | 31 Mar 2026 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
6
Latest
n/a
Rows shown
1-6 of 6
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$3,483,534 | 0 | |
| 2024 Q3 | 1,159,981 | $3,483,534 | -$2,904,199 | $3.00 | 11 |
| 2024 Q2 | 2,152,387 | $6,299,610 | +$2,590,846 | $2.93 | 12 |
| 2024 Q1 | 1,265,432 | $4,337,046 | +$2,382,665 | $3.42 | 10 |
| 2023 Q4 | 571,277 | $1,651,298 | -$144,314 | $2.89 | 9 |
| 2023 Q3 | 557,722 | $1,550,341 | +$1,550,341 | $2.78 | 10 |